Синдром Бехчета (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Синдром Бехчета" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

43^rd place

134^th place

5^th place

9^th place

2^nd place

4^th place

low place

low place

1obolibrary.org

2,299^th place

low place

4^th place

5^th place

doi.org

dx.doi.org

INTERNATIONALSTUDYGROUPFORBEHC Criteria for diagnosis of Behcet's disease // Lancet / R. Horton — Elsevier BV, 1990. — Vol. 335, Iss. 8697. — ISSN 0140-6736; 1474-547X — doi:10.1016/0140-6736(90)92643-V
d:Track:Q3430882 d:Track:Q746413 d:Track:Q939416 d:Track:Q54153154
P Kaklamanis, Sfikakis P. P., Theodossiadis P. G. et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. // Lancet / R. Horton — Elsevier BV, 2001. — Vol. 358, Iss. 9278. — P. 295–296. — ISSN 0140-6736; 1474-547X — doi:10.1016/S0140-6736(01)05497-6
d:Track:Q3430882 d:Track:Q746413 d:Track:Q54153155 d:Track:Q939416
Yilmaz E. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study // Archives of dermatology — American Medical Association, 2002. — Vol. 138, Iss. 4. — P. 467–471. — ISSN 0003-987X; 1538-3652 — doi:10.1001/ARCHDERM.138.4.467
d:Track:Q465697 d:Track:Q15749524 d:Track:Q60325747 d:Track:Q34122642
I Kötter Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis // Br. J. Ophthalmol. — BMJ, 2003. — Vol. 87, Iss. 4. — P. 423–31. — ISSN 0007-1161; 1468-2079 — doi:10.1136/BJO.87.4.423
d:Track:Q2018873 d:Track:Q24671749 d:Track:Q19859604 d:Track:Q13443571
Drug Indications Extracted from FAERS — doi:10.5281/ZENODO.1435999
d:Track:Q56863002

nih.gov

ncbi.nlm.nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074751/

obolibrary.org

purl.obolibrary.org

Disease Ontology — 2016.
d:Track:Q4117183 d:Track:Q5282129

wikidata.org

INTERNATIONALSTUDYGROUPFORBEHC Criteria for diagnosis of Behcet's disease // Lancet / R. Horton — Elsevier BV, 1990. — Vol. 335, Iss. 8697. — ISSN 0140-6736; 1474-547X — doi:10.1016/0140-6736(90)92643-V
d:Track:Q3430882 d:Track:Q746413 d:Track:Q939416 d:Track:Q54153154
Disease Ontology — 2016.
d:Track:Q4117183 d:Track:Q5282129
P Kaklamanis, Sfikakis P. P., Theodossiadis P. G. et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. // Lancet / R. Horton — Elsevier BV, 2001. — Vol. 358, Iss. 9278. — P. 295–296. — ISSN 0140-6736; 1474-547X — doi:10.1016/S0140-6736(01)05497-6
d:Track:Q3430882 d:Track:Q746413 d:Track:Q54153155 d:Track:Q939416
Yilmaz E. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study // Archives of dermatology — American Medical Association, 2002. — Vol. 138, Iss. 4. — P. 467–471. — ISSN 0003-987X; 1538-3652 — doi:10.1001/ARCHDERM.138.4.467
d:Track:Q465697 d:Track:Q15749524 d:Track:Q60325747 d:Track:Q34122642
I Kötter Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis // Br. J. Ophthalmol. — BMJ, 2003. — Vol. 87, Iss. 4. — P. 423–31. — ISSN 0007-1161; 1468-2079 — doi:10.1136/BJO.87.4.423
d:Track:Q2018873 d:Track:Q24671749 d:Track:Q19859604 d:Track:Q13443571
NDF-RT
d:Track:Q21008030
Drug Indications Extracted from FAERS — doi:10.5281/ZENODO.1435999
d:Track:Q56863002

wikipedia.org

en.wikipedia.org

INTERNATIONALSTUDYGROUPFORBEHC Criteria for diagnosis of Behcet's disease // Lancet / R. Horton — Elsevier BV, 1990. — Vol. 335, Iss. 8697. — ISSN 0140-6736; 1474-547X — doi:10.1016/0140-6736(90)92643-V
d:Track:Q3430882 d:Track:Q746413 d:Track:Q939416 d:Track:Q54153154
P Kaklamanis, Sfikakis P. P., Theodossiadis P. G. et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. // Lancet / R. Horton — Elsevier BV, 2001. — Vol. 358, Iss. 9278. — P. 295–296. — ISSN 0140-6736; 1474-547X — doi:10.1016/S0140-6736(01)05497-6
d:Track:Q3430882 d:Track:Q746413 d:Track:Q54153155 d:Track:Q939416
Yilmaz E. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study // Archives of dermatology — American Medical Association, 2002. — Vol. 138, Iss. 4. — P. 467–471. — ISSN 0003-987X; 1538-3652 — doi:10.1001/ARCHDERM.138.4.467
d:Track:Q465697 d:Track:Q15749524 d:Track:Q60325747 d:Track:Q34122642
I Kötter Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis // Br. J. Ophthalmol. — BMJ, 2003. — Vol. 87, Iss. 4. — P. 423–31. — ISSN 0007-1161; 1468-2079 — doi:10.1136/BJO.87.4.423
d:Track:Q2018873 d:Track:Q24671749 d:Track:Q19859604 d:Track:Q13443571

worldcat.org

http://www.worldcat.org/title/rheumatology-medical-knowledge-self-assessment-program-mksap-15/oclc/818341134&referer=brief_results
INTERNATIONALSTUDYGROUPFORBEHC Criteria for diagnosis of Behcet's disease // Lancet / R. Horton — Elsevier BV, 1990. — Vol. 335, Iss. 8697. — ISSN 0140-6736; 1474-547X — doi:10.1016/0140-6736(90)92643-V
d:Track:Q3430882 d:Track:Q746413 d:Track:Q939416 d:Track:Q54153154
P Kaklamanis, Sfikakis P. P., Theodossiadis P. G. et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. // Lancet / R. Horton — Elsevier BV, 2001. — Vol. 358, Iss. 9278. — P. 295–296. — ISSN 0140-6736; 1474-547X — doi:10.1016/S0140-6736(01)05497-6
d:Track:Q3430882 d:Track:Q746413 d:Track:Q54153155 d:Track:Q939416
Yilmaz E. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study // Archives of dermatology — American Medical Association, 2002. — Vol. 138, Iss. 4. — P. 467–471. — ISSN 0003-987X; 1538-3652 — doi:10.1001/ARCHDERM.138.4.467
d:Track:Q465697 d:Track:Q15749524 d:Track:Q60325747 d:Track:Q34122642
I Kötter Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis // Br. J. Ophthalmol. — BMJ, 2003. — Vol. 87, Iss. 4. — P. 423–31. — ISSN 0007-1161; 1468-2079 — doi:10.1136/BJO.87.4.423
d:Track:Q2018873 d:Track:Q24671749 d:Track:Q19859604 d:Track:Q13443571